Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded
- Contract number
- SPE2DB25FTSJ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,645
Award facts
- Contract value 100% obligated
- $3,644.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5ml units) with a ceiling value of $3,644.71 under a firm fixed-price contract. This delivery order represents a non-set-aside competitive award and is child to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Pulmozyme, a cystic fibrosis treatment, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the Defense Health System's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FTSJ5?
SPE2DB25FTSJ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FTSJ5 worth?
The government has obligated $3,645 on SPE2DB25FTSJ5.
Is contract SPE2DB25FTSJ5 an order under another contract?
Yes. SPE2DB25FTSJ5 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTSJ5 competed?
The extent of competition for SPE2DB25FTSJ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award